(Q48706402)

14 February 2018

title

Narcolepsy and obesity: remission of severe cataplexy with sibutramine. (English)

1 reference

14 February 2018

0 references

1 reference

Krahn LE

1

1 reference

14 February 2018

Moore WR

series ordinal

2

1 reference

14 February 2018

Altchuler SI

series ordinal

3

1 reference

14 February 2018

publication date

1 January 2001

1 reference

14 February 2018

number of pages

3

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

14 February 2018

volume

2

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

63-65

1 reference

14 February 2018

Hypocretin (orexin) deficiency in human narcolepsy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

A standardized test for cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Treatment of Cataplexy With Clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Absence of cardiac valve dysfunction in obese patients treated with sibutramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Sibutramine pharmacokinetics in young and elderly healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Sibutramine. A review of its contribution to the management of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2800%2900056-3

7 January 2021

10.1016/S1389-9457(00)00056-3

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018